title: [Continuous renal replacement therapy for acute kidney injury].
abstract: Acute kidney injury is common in critical illness and associated with important morbidity and mortality. Continuous renal replacement therapy (CRRT) enables physicians to safely and efficiently control associated metabolic and fluid balance disorders. The insertion of a large central venous catheter is required, which can be associated with mechanical and infectious complications. CRRT requires anticoagulation, which currently relies on heparin in most cases although citrate could become a standard in a near future. The choice of the substitution fluid depends on the clinical situation. A dose of 25 ml/kg/h is currently recommended.
authors.affiliation: Service de médecine intensive adulte, CHUV 1011, Lausanne. ludovic.aymon@chuv.ch
authors.forename: Ludovic
authors.initials: L
authors.lastname: Aymon
authors.affiliation: Service de néphrologie et consultation d'hypertension, CHUV 1011, Lausanne.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Kissling
authors.affiliation: Service de médecine intensive adulte, CHUV 1011, Lausanne.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Revelly
authors.affiliation: Service de médecine intensive adulte, CHUV 1011, Lausanne.
authors.forename: Yok-Ai
authors.initials: YA
authors.lastname: Que
authors.affiliation: Service de médecine intensive adulte, CHUV 1011, Lausanne.
authors.forename: Antoine G
authors.initials: AG
authors.lastname: Schneider
mesh_terms: D058186:Acute Kidney Injury / Q000628:therapy*; D003422:Critical Care; D005112:Extracorporeal Circulation; D006801:Humans; D017582:Renal Replacement Therapy / Q000379:methods*